GL1X · GenesisL1 explorer

Research workbench

Crystal structure of metallo-beta-lactamase vim-1 in complex with ML302F inhibitor

Analyse Crystal structure of metallo-beta-lactamase vim-1 in complex with ML302F… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5N5H
Type
protein
Length
234 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase vim-1
UniProt
Q9XAY4
Ligands
S3C, ZN
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase vim-1protein23428% helix, 28% strandQ9XAY4

Ligands and binding sites

  • S3C · (2Z)-2-sulfanyl-3-(2,3,6-trichlorophenyl)prop-2-enoic acid · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12570.580.7930ZN, S3C

Compared structures

  • 5N5H · Crystal structure of metallo-beta-lactamase VIM-1 in complex with ML302F inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.